AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 69, Issue 12 1260-1268, Copyright © 1979 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waitzkin, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waitzkin, H
A Marxian interpretation of the growth and development of coronary care technology.

H Waitzkin

Cost containment efforts will fail if they continue to ignore the structural relationships between health care costs and private profit in capitalist society. The recent history of coronary care shows that apparent irrationalities of health policy make sense from the standpoint of capitalist profit structure. Coronary care units (CCUs) gained wide acceptance, despite high costs. Studies of CCU effectiveness, using random controlled trials and epidemiologic techniques, do not show a consistent advantage of CCUs over non-intensive ward care or simple rest at home. From a Marxian perspective, the proliferation of CCUs and similar innovations is a complex historical process that includes initiatives by industrial corporations, cooperation by clinical investigators at academic medical centers, support by private philanthropies linked to corporate interests, intervention by state agencies, and changes in the health care labor force. Cost-effective methodology obscures the profit motive as a basic source of high costs and ineffective practices. Health-policy alternatives curtailing corporate involvement in medicine would reduce costs by restricting profit.




This article has been cited by other articles:


Home page
Health (London)Home page
I. D. Graham
Processes of change in obstetrics: a cross-national case-study of episiotomy
Health (London) , October 1, 1998; 2(4): 403 - 433.
[Abstract] [PDF]


Home page
Med Care Res RevHome page
W. R. Scott
Innovation in Medical Care Organizations: A Synthetic Review
Med Care Res Rev, June 1, 1990; 47(2): 165 - 192.
[PDF]


Home page
Med Care Res RevHome page
D. Mechanic
Social Policy, Technology, and the Rationing of Health Care
Med Care Res Rev, January 1, 1989; 46(2): 113 - 120.
[PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
I. F.M. Saint-Yves
At the crossroads of primary health care
The Journal of the Royal Society for the Promotion of Health, February 1, 1981; 101(1): 33 - 36.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American Public Health Association